Some US patients taking the two highest doses of Novo Nordisk s Wegovy weight-loss drug are facing difficulty filling their prescriptions, suggesting a new supply challenge for the popular medicine.
Some U.S. patients
taking the two highest doses of Novo Nordisk s Wegovy
weight-loss drug are facing difficulty filling their
prescriptions, eight doctors around the country told Reuters
this week,.
Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine.
Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy weight-loss drug are facing difficulty filling their prescriptions, eight doctors around the country told Reuters this week, suggesting a new supply challenge for the popular medicine. Wegovy is a weekly injection that can help patients shed 15% of their weight alongside diet and exercise changes. Walgreens, one of the biggest U.S. pharmacies, is experiencing supply shortages for the higher strengths, spokesperson Erin Loverher confirmed.
By Maggie Fick, Patrick Wingrove and Elissa Welle LONDON/NEW YORK (Reuters) - Some U.S. patients taking the two highest doses of Novo Nordisk's Wegovy.